Inogen
INGN
281 hedge funds and large institutions have $5.24B invested in Inogen in 2018 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 87 increasing their positions, 100 reducing their positions, and 24 closing their positions.
192% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 24
34% more capital invested
Capital invested by funds: $3.92B → $5.24B (+$1.32B)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
19% more funds holding
Funds holding: 237 → 281 (+44)
1.35% more ownership
Funds ownership: 99.19% → 100.54% (+1.3%)
13% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 100
58% less call options, than puts
Call options by funds: $29.9M | Put options by funds: $72M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$42.9M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$33.2M |
| 3 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$32.3M |
| 4 |
Morgan Stanley
New York
|
+$31.4M |
| 5 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
+$26.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$104M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$18.7M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$16.1M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$14.6M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$14.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GT
301
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$17K | -90 | Closed |
|
|
RFC
302
Regions Financial Corp
Birmingham,
Alabama
| – | -$6K | -30 | Closed |
|
303
CIBC Private Wealth Group
Atlanta,
Georgia
| – | -$4K | -21 | Closed |
|
|
LFA
304
Legacy Financial Advisors
Covington,
Kentucky
| – | -$925 | -4 | -50% |
|
|
CAG
305
Csenge Advisory Group
Clearwater,
Florida
| – | +$925 | +4 | New |
|
INGN Hedge Fund Activity: Q3 2018 in Review
281 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q3 2018, worth a combined $5.24B — up 34% from $3.92B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new INGN positions and 24 closed out — a net gain of 46 holders — while 87 added to existing stakes and 100 trimmed.
The largest buyer was Eagle Asset Management, opening a new position worth an estimated $42.9M. The largest seller was BlackRock, cutting an estimated $104M.
- 281 institutional investors held Inogen (INGN) as of Q3 2018, up from 237 in Q2 2018.
- Funds reported $5.24B of Inogen stock for Q3 2018, up 34% quarter-over-quarter.
- 70 funds opened new Inogen positions in Q3 2018 and 24 closed out, a net change of +46 holders.
- The largest Inogen buyer in Q3 2018 was Eagle Asset Management, an estimated $42.9M added.
- The largest Inogen seller in Q3 2018 was BlackRock, an estimated $104M sold.
Based on aggregated 13F filings for Q3 2018.